Comparative studies on prostanoid receptors in human non-pigmented ciliary epithelial and mouse fibroblast cell lines

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 55, Issue 4, 1996, Pages 231-240

  Liu, Lixia ^a   Eta, Ekong ^a   Bhattacherjee, Parimal ^a   Paterson, Christopher A ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11 DEOXYPROSTAGLANDIN E1; 7 [5 (4 BIPHENYLYLMETHOXY) 2 MORPHOLINO 3 OXOCYCLOPENTYL] 4 HEPTENOIC ACID; BUTAPROST; CYCLIC AMP; INOSITOL PHOSPHATE; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; PROSTANOID RECEPTOR; RECEPTOR SUBTYPE; SULPROSTONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL CULTURE; CELL LINE; CILIARY BODY EPITHELIUM; CONTROLLED STUDY; EYE; FIBROBLAST CULTURE; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; TECHNIQUE;

ANIMALIA;

EID: 0029828619     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(96)90003-4     Document Type: Article

References (69)

1. van Alphen G. W. H. M., Angel M. A. Activity of prostaglandin E, F, A and B on sphincter, dilator and ciliary muscle preparations of the cat eye. Prostaglandins 1975; 9: 157-166.
2. Eakins K. E. Prostaglandin and non-prostaglandin mediated breakdown the blood-aqueous barrier. Exp Eye Res 1977; 25 (suppl): 483-493.
3. Suzuki R., Kobayashi S. Response of bovine intra-ocular muscles to transmural stimulation in the presence of various prostaglandins. Exp Eye Res 1989; 36: 789-798.
4. Miranda O. C, Bito L. Z. The putative and demonstrated miotic effects of prostaglandins in mammals. In: Bito L, Stjernschantz J. eds. The Ocular Effects of Prostaglandins and Other Eicosanoids. New York: Liss, 1989: 171-195.
5. 2α and its isopropylester on normal and glaucomatous human eyes. In: Bito L, Stjernschantz J. eds. The Ocular Effects of Prostaglandins and Other Eicosanoids. New York: Liss, 1989: 447-458.
6. 2α analogue: Effect on intraocular pressure in patients with ocular hypertension. Br J Ophthalmol 1992; 76: 214-217.
7. Kennedy K., Coleman R. A., Humphrey P. P. A., Levy G. P., Lumley P. Studies on the characterizations of prostanoid receptors: a proposed classification. Prostaglandins 1982; 24: 667-689.
8. Coleman R. A., Humphrey P. P. A., Kennedy I., Lumley P. Prostanoid receptors: The development of a working classification. Trends Pharmacol Sci 1984; 5: 303-306.
9. Coleman R. A., Kennedy I., Humphrey P. P. A., Bunce K., Lumley P. Prostanoids and their receptors. In: Emmett J. C., ed. Comprehensive Medicinal Chemistry. Oxford: Pergamon Press, 1990: 643-714.
10. Coleman R. A., Smith W. L., Narumiya S. VIII-International Union of Pharmacology Classification of Prostanoid Receptors: Properties, Distribution and Structure of the Receptors and Their Subtypes. Pharmacol Rev 1994; 46: 205-229.
11. Coleman R. A., Grix S. P., Head S. A., Louttit J. B., Mallett A., Sheldrick R. L. G. A novel inhibitory receptor in piglet saphenous vein. Prostaglandins 1994; 47: 151-168.
12. 2-sensitive (EP-) receptors. Br J Pharmacol 1987; 91: 323P.
13. Coleman R. A., Humphrey P. P. A. Prostanoid receptors: their function and classification. In: J. R. Vane and J. O'Grady, ed. Therapeutic Applications of Prostaglandins. London: Edward Arnold, 1993: 15-17.
14. Abramovitz M., Boie Y., Nguyen T., Rushmore T. H., Bayne M. A., Metters K. M. Cloning and expression of a cDNA for the human prostanoid FP receptor. J Biol Chem 1994; 269: 2632-2636.
15. Boie Y., Sawyer N., Slipetz D. M. et al. Molecular cloning and characterization of the human DP prostanoid receptor. FASEB J 1995; 39: A1373.
16. Funk C. D., Furci L., Fitzgerald G. A. et al. Cloning and expression of a cDNA for the human prostaglandin E receptor EP1 subtype. J Biol Chem 1993; 268: 26767-26772.
17. 2 receptor. Nature 1991; 349: 617-620.
18. 3 subtype. J Biol Chem 1992; 267: 6463-6466.
19. 1 subtype of prostaglandin E receptor. J Biol Chem 1993; 268: 20175-20178.
20. 2 subtype. J Biol Chem 1993; 268: 7759-7762.
21. 2 subtype. J Biol Chem 1994; 269: 11873-11877.
22. 4 subtype. FEBS Lett 1995; 364: 339-341.
23. 2 subtype. Mol Pharmacol 1994; 46: 213-220.
24. 3 receptors: evidence of three variants with differing carboxyl termini. Br J Pharmacol 1994; 112: 377-385.
25. 2. Eur J Biochem 1995; 228: 23-30.
26. 3 receptor with different carboxyl-terminal domains. J Biol Chem 1993; 268: 2712-2718.
27. Namba T., Sugimoto Y., Negishi M. et al. Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature 1993; 365: 166-170.
28. 2 receptor. J Biol Chem 1984; 269: 6163-6169.
29. 2 binding sites distribution and subtype classification in the rabbit iris-ciliary body. Prostaglandins 1992; 44: 199-208.
30. 2α. binding sites in the bovine iris ciliary body. Invest Ophthalmol Vis Sci 1993; 34: 2237-2245.
31. 2. In: Samuelsson B., Paoletti R., Ranwell P. W., eds. Advances in Prostaglandin, Thromboxane, and Leukotriene Research Vol 21. New York: Raven Press, 1990: 371-374.
32. 2α, of phosphatidic acid phosphatidyl-inositol turnover in rat luteal cells. Biochem Biophys Res Commun 1983; 116: 39-46.
33. 2+ transients evoked by prostanoids in Swiss 3T3 cells suggest an FP-receptor mediated response. In: Samuelson B., Paoletti R., Ramwell P. W., eds. Advances in Prostaglandin, Thromboxane, and Leukotriene Research, Vol 21. New York: Raven Press; 1990: 367-370.
34. 2+ signals in Swiss 3T3 cells are mediated by a single (FP) receptor. Biochem Pharmacol 1994; 47: 1567-1574.
35. Chen M., Amirian D., Toomey M., Sanders M. J., Soil A. H. Prostanoid inhibition of canine parietal cells: mediation by the inhibitory guanosine triphosphate-binding protein of adenylate cyclase. Gastroenterology 1988; 94: 1121-1129.
36. Bhattacherjee P., Rhodes L., Paterson C. A. Prostaglandin ' receptors coupled to adenylate cyclase in the bovine iris-ciliary body of rabbits, cats and cows. Exp Eye Res 1993; 56: 327-333.
37. +-ATPase subunit isoforms in the human ciliary body and cultured ciliary epithelial cells. J Cell Physiol 1989; 141: 243-252.
38. Bhattacherjee P., Perrin M., Jacobs N., Robinson R., Paterson C. A. Prostaglandin receptors and binding sites in rabbit nonpigmented epithelial cells. Invest Ophthalmol Vis Sci 1993; 34(suppl): 824.
39. 2-receptor stimulated cyclic AMP synthesis in cultured human non-pigmented ciliary epithelium. Exp Eye Res 1994; 58: 563-566.
40. Gusovsky F. Prostaglandin receptors in NIH 3T3 cells: Coupling of one receptor to adenylate cyclase and of a second receptor to phospholipase C. Mol Pharmacol 1991; 40: 633-638.
41. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-275.
42. Berridge M. J., Dawson R. M. C., Downes C. P., Helsop J. P., Irvine R. F. Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides. Biochem J 1983; 212: 473-482.
43. Yamaguchi D. T., Hahn T. J., Iida-Klein A., Kleeman C. R., Muallem S. Parathyroid hormone activated calcium channels in an osteoblast-like clonal osteosarcoma cell line. J Biol Chem 1987; 262: 7711-7718.
44. 2+ indication with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440-3450.
45. Lee C. H., Reisine T. D., Wax M. B. Alterations of intracellular calcium in human non-pigmented ciliary epithelial cells of the eye. Exp Eye Res 1989; 48: 733-743.
46. Dong Y. J., Jones R. L., Wilson N. H. Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostablandin analogues. Br J Pharmacol 1986; 87: 97-107.
47. Woodward D. F., Lawrence R. A., Fairbairn C. E., Shan T., Williams L. S. Intraocular pressure effects of selective prostanoid receptor agonists involve different receptor subtypes according to radioligand binding studies. J Lipid Mediat 1993; 6: 545-553.
48. Milne S. A., Armstrong R. A., Woodward D. F. Comparison of the EP receptor subtypes mediating relaxation of the rabbit jugular and pig saphaenous veins. Prostaglandins 1995; 49: 225-237.
49. Smithson M., Bhattacherjee P., Paterson C. Prostanoid receptors and signal transduction in ciliary body and iris-sphincter muscle of cows, cats and humans. Invest Ophthalmol Vis Sci 1995; 36: 594.
50. 2-adrenergic receptors. Proc Natl Acad Sci USA 1986; 83: 8754-8758.
51. Wax M. B., Coca-Prados M. Receptor-mediated phosphoinositide hydrolysis in human ocular ciliary epithelial cells. Invest Ophthalmol Vis Sci 1989; 30: 1675-1679.
52. Crook R. B., Bazan N. G., Polansky J. R. Histamine H occupancy triggers inositol phosphate and intracellular calcium mobilization in human non-pigmented ciliary epithelial cells. Curr Eye Res 1991; 10: 5930-6000.
53. Crook R. B., Polansky J. R. Neurotransmitters and neuropeptides stimulates inositol phosphates and intracellular calcium in cultured human nonpigmented ciliary epithelium Invest Ophthalmol Vis Sci 1992; 33: 1706-1716.
54. Mito T., Delamere N. A., Coca-Prados M. Calcium-dependent regulation of cation transport in cultured human nonpigmented ciliary epithelial cells. Am J Physiol 1993; 264: C519-C526.
55. 2+ mobilization in nontransformed ciliary nonpigmented epithelial cells. Invest Ophthalmol Vis Sci 1992; 33: 1696-1705.
56. Woolkalis M. J., Nakada M. T., Manning D. R. Alterations in the component of adenylate cyclase associated with transformation of chicken embryo fibroblasts by Rous Sarcoma Virus. J Biol Chem 1986; 261: 3408-3413.
57. 2 receptor subtype. Invest Ophthalmol Vis Sci 1990; 31: 2463-2466.
58. Delamere N. A., Parkerson J. Arachidonic acid metabolism alters the Na, K-ATPase response to protein kinase C activation. J Cell Biochem 1994; 18D suppl: 30.
59. 1 on exudative and tissue components of granulomatous inflammation on rats. Br J Pharmacol 1979; 65: 465-472.
60. 2 elevation of cyclic AMP in granuloma macrophages at various stages of inflammation: Relevance to anti-inflammatory and immunomodulatory functions. Prostaglandins 1981; 22: 95-103.
61. Bhattacherjee P. The role of arachidonate metabolites in ocular inflammation. In: Bito L., Stjernschantz J. eds. The Ocular Effects of Prostaglandins and Other Eicosanoids. New York: Liss, 1989: 211-227.
62. 2 in perfused rat lungs injured with hydrogen peroxide. J Pharmacol Exp Ther 1987; 241: 1-5.
63. Wong K. L., Howes E. L. Intraocular injection of prostaglandins modification response to circulating bacterial endotoxin. Arch Ophthalmol 1983; 101: 275-279.
64. 2: Apparent correlation with in vivo modulation of mediator release. Proc Natl Acad Sci USA 1988; 85: 2315-2319.
65. Kunkel S. L., Thrall R. S., Kunkel R. G., McCormick J. R., Ward P. A., Zurier R. A. Suppression of immune complex vascularitis in rats by prostaglandins. J Clin Invest 1979; 64: 1525-1529.
66. Ninneman J. R. Monocytes and macrophages. In: Prostaglandins, Leukotrienes and the Immune Response. Cambridge: Cambridge University Press, 1988: 34-52.
67. Goetzl E. J., Gorman R. R. Chemotactic and chemokinetic human eosinophil and neutrophil polymorphonuclear leukocytes by 12-L-hydroxy-5,8,10-heptadecatrienoic acid (HHT). J Immunol 1979; 120: 526-531.
68. 1 inhibits chemoattractant-induced mitogen-activated protein kinase activity in human neutrophils. In: Samuelson B., Paoletti R., Ramwell P. W., eds. Advances in Prostaglandin, Thromboxane, and Leukotriene Research, Vol 23. New York: Raven Press 1995: 311-316.
69. Michael J., Busch W. M., Eric J. G. M., van Oosterhout, Hoyng P. Effects of cyclic nucleotide analogues on intraocular pressure and trauma-induced inflammation in the rabbit eye. Curr Eye Res 1992; 11: 5-13.